BioSpace News Archive

Arbor Diagnostics, a Dallas-based pathology practice, is the first group based in North Texas to offer Roche’s SARS-CoV-2 Total Antibody Serology test to local healthcare providers.

Citius Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced that it is providing free access to Mino-Lok® for healthcare providers under an Expanded Access protocol to ease the burden associated with the COVID-19 pandemic.

Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today it received CE mark certification for the 14-Day version of the Carnation Ambulatory Monitor (“CAM”) patch, the industry’s only P-wave centric ambulatory cardiac patch monitor and arrhythmia detectio

– New project seeks to expand on positive preliminary results from ongoing research program with McMaster University to develop innovative drug delivery systems using disruptive PGX Technology – Ceapro at the forefront of pioneering approaches with natural products through utilizing validated enabling technology

Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing treatments for rare and specialty diseases with significant unmet needs, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Intravenous (IV) Choline Chloride for the treatment of intestinal failure-associated liver disease (IFALD). IV Choline Chloride is the Company’s Phase 3-ready investigational phospholipid substrate re

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced that it received written communication from the U.S. Food and Drug Administration (FDA) that the clinical dev

A research team from Colorado State University, Virginia Tech and GenoFAB – a cloud computing company focused on high-throughput laboratory automation – have completed one of the largest quantitative experiments looking at the genetic control of cell growth and division in yeast.

Newly-completed series of patient guidelines from National Comprehensive Cancer Network shares expert advice with patients and caregivers on treatment and prevention for most common head and neck cancers.

BioLineRx Ltd. (Nasdaq: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today announced that it has entered into definitive agreements with several healthcare-focused, institutional and accredited investors for the purchase and sale of 5,142,859 of the Company’s American Depositary Shares (ADSs

Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced that the positive results of a single-arm, open-label, Phase 1 study of CPI-613 ® (devimistat) with gemcitabine and nab-paclitaxel in patients with locally advanced or metastatic pancreatic cancer, will be presented in a poster presentation at the American Society of Clinical Oncology (ASCO) 2020 Vi